Application Nr Approved Date Route Status External Links
ANDA202602 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Exemestane Tablets Are An Aromatase Inhibitor Indicated For: Adjuvant Treatment Of Postmenopausal Women With Estrogen-Receptor Positive Early Breast Cancer Who Have Received Two To Three Years Of Tamoxifen And Are Switched To Exemestane Tablets For Completion Of A Total Of Five Consecutive Years Of Adjuvant Hormonal Therapy ( 14.1 ). The Treatment Of Advanced Breast Cancer In Postmenopausal Women Whose Disease Has Progressed Following Tamoxifen Therapy ( 14.2 ). 1.1 Adjuvant Treatment Of Postmenopausal Women Exemestane Tablets Are Indicated For Adjuvant Treatment Of Postmenopausal Women With Estrogen-Receptor Positive Early Breast Cancer Who Have Received Two To Three Years Of Tamoxifen And Are Switched To Exemestane Tablets For Completion Of A Total Of Five Consecutive Years Of Adjuvant Hormonal Therapy [See Clinical Studies ( 14.1 )]. 1.2 Advanced Breast Cancer In Postmenopausal Women Exemestane Tablets Are Indicated For The Treatment Of Advanced Breast Cancer In Postmenopausal Women Whose Disease Has Progressed Following Tamoxifen Therapy [ See Clinical Studies ( 14.2 ) ].

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Exemestane EXEMESTANE ZINC3973334

Comments